1 completed, 1 recruiting. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Recruiting 1 |
Follow ATM-AVI: new trials by email Literature Review of ATM-AVI trials Research Report on ATM-AVI
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of 2 Medicines (Aztreonam and Avibactam) Compared to Best Available Therapy for Serious Gram-negative Infections ATM-AVI, BAT - Gram-negative Bacterial Infections | Phase 2 | Recruiting | Pfizer | 48 | 2023-04-18 | 2026-10-29 |
| Determine the PK and Safety and Tolerability of ATM-AVI for the Treatment of cIAIs in Hospitalized Adults (REJUVENATE) ATM-AVI, Metronidazole - Complicated Intra-Abdominal Infections, cIAIs | Phase 2 | Completed | Pfizer | 40 | 2016-05-19 | 2020-04-02 |
Gram-Negative Bacterial Infections (1)
Pfizer (2)
Spain (2) · China (1) · France (1) · Germany (1) · Greece (1) · Hungary (1) · India (1) · Taiwan (1) · Turkey (Türkiye) (1) · United States (1)
Oliver Cornely (1)
PMID 31828337, PMID 35115349, PMID 38252170
2015 (1)